Early postoperative bridging anticoagulation after mechanical heart valve replacement: a systematic review and meta-analysis
- PMID: 26178802
- DOI: 10.1111/jth.13047
Early postoperative bridging anticoagulation after mechanical heart valve replacement: a systematic review and meta-analysis
Abstract
Objective: To perform a systematic review and meta-analysis of studies evaluating anticoagulation during the early postoperative period following mechanical heart valve implantation.
Methods: Five literature databases were searched to assess the rates of bleeding and thromboembolic events among patients receiving oral anticoagulation (OAC), both with and without bridging anticoagulation therapy with unfractionated heparin (UFH) or subcutaneous low molecular weight heparin (LMWH). The studies' results were pooled via a mixed effects meta-analysis. Heterogeneity (I(2) ) and publication bias were both evaluated.
Results: Twenty-three studies including 9534 patients were included. The bleeding rates were 1.8% (95% confidence interval CI 1.0-3.3) in the group receiving OAC, 2.2% (95% CI 0.9-5.3) in the OAC + UFH group, and 5.5% (95% CI 2.9-10.4) in the OAC + LMWH group (P = 0.042). The thromboembolic event rate was 2.1% (95% CI 1.5-2.9) in the group receiving OAC, as compared with 1.1% (95% CI 0.7-1.8) when the bridging therapy groups were combined as follows: OAC + UFH and OAC + LMWH (P = 0.035). Most of the analyses showed moderate heterogeneity and negative test results for publication bias.
Conclusions: Bridging therapy following cardiac valve surgery was associated with a lower thromboembolic event rate, although the difference was small, with considerable overlap of the CIs. Direct comparisons are missing. Bridging therapy with UFH appears to be safe; however, this observation has a risk of bias. Early bridging therapy with LMWH appears to be associated with consistently high bleeding rates across multiple analyses. On the basis of the quality of the included studies, more trials are necessary to establish the clinical relevance of bridging therapy and the safety of LMWH.
Keywords: anticoagulants; cardiac surgical procedures; heart valve diseases; heart valve prosthesis implantation; meta-analysis.
© 2015 International Society on Thrombosis and Haemostasis.
Similar articles
-
Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD007557. doi: 10.1002/14651858.CD007557.pub3. Cochrane Database Syst Rev. 2017. PMID: 28431186 Free PMC article.
-
Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007557. doi: 10.1002/14651858.CD007557.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Apr 21;4:CD007557. doi: 10.1002/14651858.CD007557.pub3. PMID: 22972111 Updated.
-
Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion.Cochrane Database Syst Rev. 2025 Jan 28;1(1):CD013816. doi: 10.1002/14651858.CD013816.pub2. Cochrane Database Syst Rev. 2025. PMID: 39873294
-
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD001100. doi: 10.1002/14651858.CD001100.pub4. Cochrane Database Syst Rev. 2017. PMID: 28182249 Free PMC article.
-
Pentasaccharides for the prevention of venous thromboembolism.Cochrane Database Syst Rev. 2016 Oct 31;10(10):CD005134. doi: 10.1002/14651858.CD005134.pub3. Cochrane Database Syst Rev. 2016. PMID: 27797404 Free PMC article.
Cited by
-
Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update.Gut. 2021 Sep;70(9):1611-1628. doi: 10.1136/gutjnl-2021-325184. Gut. 2021. PMID: 34362780 Free PMC article.
-
Predictors for blood loss and transfusion frequency to guide blood saving programs in primary knee- and hip-arthroplasty.Sci Rep. 2021 Feb 23;11(1):4386. doi: 10.1038/s41598-021-82779-z. Sci Rep. 2021. PMID: 33623079 Free PMC article.
-
Low molecular weight heparin in surgical valve procedures: When and how much for an optimal prophylaxis?Cardiol J. 2020;27(5):548-557. doi: 10.5603/CJ.a2018.0146. Epub 2018 Nov 28. Cardiol J. 2020. PMID: 30484265 Free PMC article.
-
2024 EACTS/EACTAIC Guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP.Interdiscip Cardiovasc Thorac Surg. 2025 May 6;40(5):ivae170. doi: 10.1093/icvts/ivae170. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 39385501 Free PMC article. No abstract available.
-
Outcome and safety comparison of low-molecular-weight heparin versus unfractionated heparin for bridging anticoagulation in individuals with mechanical heart valves undergoing non-cardiac surgery: A systematic review and meta-analysis.Narra J. 2025 Apr;5(1):e1254. doi: 10.52225/narra.v5i1.1254. Epub 2025 Feb 3. Narra J. 2025. PMID: 40352202 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical